The blockade of Notch signaling, which is targeted by GSI-I, can enhance the radiosensitivity of glioblastoma cell lines, inhibit xenograft and tumor neurosphere growth, and lead to the depletion of CD133-positive glioblastoma cells [166]. This evidence concerns the gene PROM1 and neoplasm.